ETV7 promotes 5-FU resistance and malignant progression through CXCL1-induced NETs formation in colorectal cancer

Read full text Summarise with VIRAT
Authors: Shuang Mo, Pei Xia, Yongrui Lv, Lei Liu, Shujin He, Huabin Gao, Lin Chen, Jie Wu, Anjia Han, Lixia Chen
Cited by: 0
References: 36

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Resistance to 5-fluorouracil (5-FU) remains a major challenge in the treatment of colorectal cancer (CRC). Here, we identify ETS variant transcription factor 7 (ETV7) as significantly upregulated in CRC tissues and cell lines, with elevated expression associated with poor clinical prognosis. Functional assays demonstrate that ETV7 enhances CRC cell proliferation, invasion, and resistance to 5-FU. Mechanistically, ETV7 transcriptionally upregulates CXCL1, leading to increased neutrophil recruitment and enhanced formation of neutrophil extracellular traps (NETs). The resulting NETs-enriched tumor microenvironment promotes tumor aggressiveness and chemoresistance. Pharmacological inhibition of CXCL1 or degradation of NETs effectively attenuates ETV7-driven malignant phenotypes in vitro and in vivo. Collectively, these findings establish an ETV7–CXCL1–NETs axis that contributes to 5-FU resistance in CRC and suggest that targeting this pathway may improve chemotherapy response. ETV7 drives colorectal cancer progression and 5-fluorouracil resistance by upregulating CXCL1, which promotes neutrophil recruitment and NET formation, creating a pro-tumor microenvironment. Targeting this ETV7–CXCL1–NETs axis reduces chemoresistance and tumor aggressiveness.

Fields of Study & Subjects

Neutrophil Myeloperoxidase and Oxidative Mechanisms Colorectal Cancer Treatments and Studies Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Communications Biology
Volume
9
Issue
1
Pages
472
Publication date
31 March 2026
Language
EN